New Brunswick health officials are moving forward in their investigation of a mystery brain disease that has raised concerns.
An initial analysis of patient data is complete and is now being reviewed by the Public Health Agency of Canada to help determine next steps, according to a government release.
The investigation began in 2021 when a group of 48 patients reported unusual neurological symptoms. A report issued in 2022 found no evidence of a single illness affecting them.
However, in 2023, new cases emerged, prompting further research into potential environmental factors.
Since then, the Office of the Chief Medical Officer of Health has worked with the Vitalité Health Network and the Public Health Agency of Canada to collect and analyze more patient data.
Officials say understanding possible environmental connections is a key part of the current investigation, according to a government release.
Chief Medical Officer of Health Dr. Yves Léger says the review will ensure the findings are thorough and reliable.
“This will help us determine what needs to happen next to support affected patients and their families,” Léger said.
Although many are eager for answers, Léger emphasized that the process must be completed before results are shared.
“We want to ensure we have confidence in the findings from this work,” he said.
A final report is expected this summer, with recommendations and next steps to follow.
As the investigation continues, officials have also introduced new resources to support those affected.
To support patients and their families, the province has launched a toll-free information line.
Residents can call 1-866-506-9355 to get updates about the investigation and access mental health support.
The line operates from 8 a.m. to 8 p.m. for general inquiries, while mental health services are available 24/7.
